Skip to main content
Monday, November 16, 2026Nov 16

As monkeypox drops in the West, still no vaccines for Africa

FILE - A man holds a sign urging increased access to the monkeypox vaccine during a protest in San Francisco on July 18, 2022. With monkeypox cases subsiding in Europe and parts of North America, many scientists say now is the time to prioritize stopping the virus in Africa. (AP Photo/Haven Daley, File)
FILE - A man holds a sign urging increased access to the monkeypox vaccine during a protest in San Francisco on July 18, 2022. With monkeypox cases subsiding in Europe and parts of North America, many scientists say now is the time to prioritize stopping the virus in Africa. (AP Photo/Haven Daley, File)

ABUJA, Nigeria (AP) — With monkeypox cases subsiding in Europe and parts of North America, many scientists say now is the time to prioritize stopping the virus in Africa.

In July, the U.N. health agency designated monkeypox as a global emergency and appealed to the world to support African countries so that the catastrophic vaccine inequity that plagued the outbreak of COVID-19 wouldn’t be repeated.

But the global spike of attention has had little impact on the continent. No rich countries have shared vaccines or treatments with Africa, and some experts fear interest may soon evaporate.

“Nothing has changed for us here, the focus is all on monkeypox in the West,” said Placide Mbala, a virologist who directs the global health research department at Congo’s Institute of Biomedical Research.

“The countries in Africa where monkeypox is endemic are still in the same situation we have always been, with weak resources for surveillance, diagnostics and even the care of patients,” he said.